---

Fertility-Preserving Strategies in Gynecological Surgery for Young Females

---

I. GENERAL PRINCIPLES OF FERTILITY PRESERVATION

• Patient's age, fertility desires, and reproductive history
• Stage and grade of the disease
• Need for adjuvant chemotherapy/radiation
• Possibility of pre-treatment ART (assisted reproductive technology)

"Fertility sparing treatments may be considered in certain situations including radical trachelectomy for cervical cancer, progestin therapy in lieu of hysterectomy for uterine cancer, and unilateral oophorectomy for some ovarian tumors. Ovarian function may be preserved when ovarian transposition is performed prior to radiation therapy." - Berek & Novak's Gynecology

---

II. FERTILITY PRESERVATION BY CONDITION

1. Cervical Cancer (Most Common Gyn Cancer in Young Women)

• Tumor ≤2 cm, no LVSI/nodal involvement
• Upper cervix preserved, contiguous with uterus
• Subsequent pregnancies via cesarean section
• Laparoscopic/robotic approach preferred for reduced blood loss (median loss ~62.5 mL in robotic series)

• Berek & Novak's Gynecology, section on Cervical Cancer With Desire for Fertility

---

2. Endometrial Cancer / Hyperplasia

• Continuous oral progestins (medroxyprogesterone acetate 160-320 mg/day or megestrol acetate)
• Levonorgestrel-releasing IUD (LNG-IUD/Mirena) - achieves higher local endometrial concentrations
• GnRH agonist as adjunct to progestin therapy
• Repeat endometrial sampling every 3-6 months to confirm regression
• Definitive hysterectomy after completion of childbearing

1. Grade 1 endometrioid carcinoma
2. Disease limited to endometrium (no myometrial invasion on MRI)
3. No extrauterine disease
4. Patient counseled regarding risk of concurrent/future progression
5. Willing and able to comply with close surveillance

"For selected young women who have low-grade endometrial cancer and who desire to preserve fertility, or in women who are not medically fit for surgery, continuous progestin-based therapy with repeat endometrial sampling every 3 to 6 months can..." - Goldman-Cecil Medicine

---

3. Ovarian Tumors

a. Borderline (Low Malignant Potential) Tumors

• Unilateral oophorectomy or ovarian cystectomy is safe for apparent stage I borderline tumors
• Lim-Tan et al.: only 8% recurrence rate 2-18 years post-conservative surgery; all recurrences were curable
• Recurrence associated with positive cyst margins - careful complete excision is essential
• Frozen section intraoperatively helps guide the extent of surgery
• No adjuvant chemotherapy needed

• Berek & Novak's Gynecology, Neoplastic Masses

b. Malignant Epithelial Ovarian Cancer - Early Stage

• Stage IA, Grade 1-2: Unilateral salpingo-oophorectomy (USO) + comprehensive staging is acceptable
• Contralateral ovary and uterus preserved
• Strict surveillance: periodic pelvic exams + CA-125 monitoring
• Contralateral ovary and uterus removed after childbearing is complete
• GOG trial: 5-year survival 94-96% for Stage IA/IB G1-2 with observation alone - no adjuvant therapy needed

"The uterus and the contralateral ovary can be preserved in women with stage IA, grade 1 to 2 disease who desire to preserve fertility." - Berek & Novak's Gynecology

c. Non-Epithelial Ovarian Tumors (Germ Cell, Sex Cord-Stromal)

• Dysgerminoma, immature teratoma, granulosa cell tumor - all highly amenable to fertility-sparing surgery
• Unilateral salpingo-oophorectomy + staging (even for bilateral dysgerminoma - stage IA)
• Highly chemosensitive (BEP regimen), so fertility-sparing approach is standard of care in young women
• Androgen-producing tumors (Sertoli-Leydig): USO if stage IA

---

4. Uterine Fibroids (Leiomyomas)

• Myomectomy (abdominal, laparoscopic, hysteroscopic depending on fibroid location) is the fertility-preserving surgical option
• Indicated for symptomatic patients desiring future fertility
• Hysterectomy should only be offered to symptomatic patients who have completed childbearing
• GnRH agonists (e.g., leuprolide acetate) pre-operatively reduce uterine size, decrease operative blood loss, allow minimally invasive approach

"Fertility-preserving surgical management (myomectomy) is possible in most patients with leiomyomas." - Berek & Novak's Gynecology

---

5. Endometriosis

• Fertility-preserving approach: conservative laparoscopic surgery - excision of endometriotic implants, cystectomy for endometriomas, adhesiolysis
• Bilateral salpingo-oophorectomy reserved for severe/refractory disease in women who have completed childbearing
• 76% of women with fertility-preserving operation had symptom relief at 5 years

---

III. ADJUNCTIVE FERTILITY PRESERVATION STRATEGIES

1. Ovarian Transposition (Oophoropexy)

• Performed before pelvic radiation to move ovaries out of radiation field
• Ovaries sutured lateral to iliac crests or behind the uterus
• Preserves hormonal function and oocyte reserve
• Recommended before chemoradiation for cervical cancer

2. ART - Pre-treatment Fertility Preservation

• Embryo cryopreservation (most established) - if partner available
• Oocyte cryopreservation - now non-experimental; increasingly used
• Ovarian tissue cryopreservation - still largely experimental; risk of reimplanting malignant cells in some cancers
• Requires 10-14 days of ovarian stimulation - acceptable delay for most solid tumors
• In vitro maturation (IVM) - experimental; avoids stimulation delay

3. GnRH Analog Co-treatment During Chemotherapy

• Aims to suppress ovarian function during chemotherapy to reduce gonadotoxicity
• Still considered investigational; uncertain protective efficacy
• May be offered alongside standard ART in younger patients

---

IV. POST-TREATMENT REPRODUCTIVE OUTCOMES

---

V. COUNSELING AND ETHICAL CONSIDERATIONS

1. Informed consent: clearly explain oncologic risk of conservative approach vs. standard treatment
2. Document patient's understanding of surveillance requirements
3. Genetic counseling for BRCA1/2 carriers (higher risk bilateral/future ovarian cancer)
4. Psychological support - fertility anxiety is significant
5. Multi-disciplinary team involvement: gynecologic oncologist + reproductive endocrinologist + perinatologist
6. Fertility preservation should be time-sensitive - referral to reproductive specialist before treatment initiation

---

SUMMARY TABLE

---

• Berek & Novak's Gynecology (Sections: Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Preservation of Fertility in Cancer Patients, Leiomyomas)
• Goldman-Cecil Medicine, 2 Volume Set (Treatment of Endometrial Cancer)
• Creasy & Resnik's Maternal-Fetal Medicine (Cervical Carcinoma in Pregnancy)